Review article: Irritable bowel syndrome

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 1, 1997, Pages 3-15

  Camilleri, M ^a,b   Choi, M G ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; DIPHENOXYLATE; LOPERAMIDE; VERAPAMIL;

ADULT; AGE; AGED; CONSTIPATION; DIARRHEA; FEMALE; HUMAN; INTESTINE MOTILITY; IRRITABLE COLON; LACTOSE INTOLERANCE; MALE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SEX DIFFERENCE;

EID: 0031030741     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.84256000.x     Document Type: Review

References (109)

1. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards a positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653-4.
2. Thompson WG, Dotevall G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989: 2: 92-5.
3. Talley NJ, Phillips SF, Melton LJ, et al. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990; 31: 77-81.
4. Chaudhary NA, Truelove SC. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med 1962; 31: 307-22.
5. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Dig Dis Sci 1993; 38: 1569-80.
6. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-34.
7. Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Dig Dis Sci 1993; 38: 1581-9.
8. Zuckerman MJ, Guerra LG, Foland JA, Drossman DA, Gregory G. Comparison of bowel patterns in Hispanics and whites. Gastroenterology 1990; 98: A403. (Abstract.)
9. Taub E, Cuevas JL, Cook EW, Crowell M, Whitehead WE. Irritable bowel syndrome defined by factor analysis: gender and race comparisons. Dig Dis Sci 1995; 40: 2647-55.
10. Agreus L, Svardsudd K, Nyren O, et al. The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. Scand J Gastroenterol 1994; 29: 102-9.
11. Heaton KW, Ghosh S, Braddon FEM. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991; 32: 73-9.
12. Jones R, Lydiard S. Irritable bowel syndrome in the general population. Br Med J 1992; 304: 87-90.
13. Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med 1994; 236: 23-30.
14. Schlemper RJ, van der Werf SDJ, Vandenbroucke JP, Biemond I, Lamers CB. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and japan. Scand J Gastroenterol 1993; 28: 33-41.
15. Bi-zhen W, Qi-ying P. Functional bowel disorders in apparently healthy Chinese people. Chin J Epidemiol 1988; 9: 345-9.
16. Massarrat S, Saberi-Firoozi M, Soleimani A, et al Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995; 7: 427-33.
17. Sandier RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990; 99: 409-15.
18. Jain AP, Gupta OP, Jajoo UN, Sidhwa HK. Clinical profile of irritable bowel syndrome at a rural based teaching hospital in central India. J Assoc Physicians India 1991; 39: 385-6.
19. Kay L, Jorgensen T, Schultz-Larsen K. Colon related symptoms in a 70-year-old Danish population. J Clin Epidemiol 1993; 46: 1445-9.
20. Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992; 102: 895-901.
21. Talley NJ, Zinsmeister AR, Melton LJ. Irritable bowel syndrome in a community : symptom subgroups, risk factors and health care utilization. Am J Epidemiol 1995; 142: 76-83.
22. Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991; 100: 998-1005.
23. Drossman DA, McKee DC, Sandier RS, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988; 95: 701-8.
24. Lydiard RB, Laraia MT, Howell EF, Ballenger JC. Can panicdisorder present as irritable bowel syndrome ? J Clin Psychiatry 1986; 47: 470-3.
25. Whitehead WE, Bosmajian L, Zonderman AB, Costa PT, Schuster MM. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988; 95: 709-14.
26. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms : subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33: 825-30.
27. Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA. Sexual and physical abuse and gastrointestinal illness. Ann Intern Med 1995; 123: 782-94.
28. Talley NJ, Fett SL, Zinsmeister AR. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol 1995; 90: 366-71.
29. Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology 1994; 107: 1040-9.
30. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 671-80.
31. Kruis W, Thieme C, Weinzierl M, et al. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984; 87: 1-7.
32. Camilleri M, Neri M. Motility and stress. Dig Dis Sci 1989; 34: 1777-86.
33. Alvarez WC. Ways in which emotion can affect the digestive tract: and Help in sizing up the patient. In: Nervousness, Indigestion and Pain. New York: Paul B. Hoeber, 1943; 1-21 and 83-99.
34. Almy TP, Tulin M. Alterations in man under stress. Experimental production of changes simulating the 'irritable colon'. Gastroenterology 1947; 8: 616-26.
35. Connell AM. The motility of the pelvic colon. II. Paradoxical motility in diarrhoea and constipation. Gut 1962; 3: 342-8.
36. Chaudhary NA, Truelove SC. Human colonic motility: A comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable colon syndrome. I. Resting patterns of motility. Gastroenterology 1961; 40: 1-17.
37. Horowitz L, Farrar JT. Intraluminal small intestinal pressure in normal patients and in patients with functional gastrointestinal disorders. Gastroenterology 1962; 42: 455-64.
38. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987; 92: 1885-93.
39. Gorard DA, Libby GW, Farthing MJ. Ambulatory small intestinal motility in diarrhoea predominant irritable bowel syndrome. Gut 1994; 35: 203-10.
40. Whitehead WE, Engel BT, Schuster MM. Irritable bowel syndrome. Physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci 1980; 25: 404-13.
41. Bazzocchi G, Ellis J, Meyer J, et al. Colonic scintigraphy and manometry in constipation, diarrhea and inflammatory bowel disease. Gastroenterology 1988; 94: 29. (Abstract.)
42. Bazzocchi G, Ellis J, Villaneuva-Meyer J, et al. Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology 1990; 98: 686-93.
43. Cann PA, Read NW, Brown C, Hobson N, Holdsworth CD. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 1983: 24: 405-11.
44. Vassallo M, Camilleri M, Phillips SF, et al. Transit through the proximal colon influences stool weight in irritable bowel syndrome. Gastroenterology 1992; 102: 102-8.
45. Stivland T, Camilleri M, Vassallo M, et al. Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology 1991; 101: 107-15.
46. Camilleri M, Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders. Gastroenterology 1996; in press.
47. Camillerii M. Diarrhea and irritable bowel syndrome: practical approaches. In: Nicholls RJ, Dozois RR. eds. Surgery of the Colon and Rectum. London: Churchill Livingstone, 1996: in press.
48. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable bowel syndrome. Gut 1973; 14: 125-32.
49. Prior A, Maxton DG, Whorwell JP. Anorectal manometry in irritable bowel syndrome : differences between diarrhoea and constipation predominant subjects. Gut 1990; 31: 458-62.
50. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
51. Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990; 99: 1688-704.
52. Drossman DA, McKee DC, Sandier RS, et al. Psychosocial factors in the irritable bowel syndrome : a multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988; 95: 701-8.
53. Whitehead WE, Bosmajian L, Zonderman A, Costa PT, Schuster MM. Role of psychologic symptoms in irritable bowel syndrome: comparison of community and clinic samples. Gastroenterology 1988; 95: 709-14.
54. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology 1989; 97: 775-7.
55. McDonald AJ, Bouchier IA. Non-organic gastrointestinal illness: a medical and psychiatric study. Br J Psychiatry 1980; 136: 276-83.
56. Craig TK, Brown GW. Goal frustration and life events in the aetiology of painful gastrointestinal disorder. J Psychosom Res 1984; 28: 411-21.
57. Ford MJ, Miller PM, Eastwood J, Eastwood MA. Life events, psychiatric illness and the irritable bowel syndrome. Gut 1987; 28: 160-5.
58. Colgan S, Creed F, Klass H. Symptom complaints, psychiatric disorder and abnormal illness behaviour in patients with upper abdominal pain. Psychol Med 1988; 18: 887-92.
59. Blanchard EB, Scharff L, Schwarz SP, Suis JM, Barlow DH. The role of anxiety and depression in the irritable bowel syndrome. Behave Res Ther 1990; 28: 401-5.
60. Painter NS. Irritable or irritated bowel. Br Med J 1972; ii: 46.
61. McMichael HB, Webb J, Dawson AM. Lactase deficiency in adults: a cause of functional diarrhoea. Lancet 1965: i: 717-20.
62. Bayless TM, Rosensweig NS. A racial difference in incidence of lactase deficiency: a survey of milk intolerance and lactase deficiency in healthy adult males. J Am Med Assoc 1966; 197: 968-72.
63. Newcomer AD, McGill DB. Irritable bowel syndrome: role of lactase deficiency. Mayo Clin Proc 1983; 59: 339-41.
64. Hyams JS. Sorbitol intolerance: an unappreciated cause of functional gastrointestinal complaints. Gastroenterology 1983; 84: 30-3.
65. Rumessen JJ, Gudmand-Hoyer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol and fructose-sorbitol mixtures. Gastroenterology 1988; 95: 694-700.
66. Nelis GF, Vermeeren M, Jansen W. Does fructose-sorbitol malabsorption (FSM) play a role in the aetiology of the irritable bowel syndrome? Gastroenterology 1990; 98: A194. (Abstract.)
67. Scott RB, Dramant SC, Gall DG. Motility effects of intestinal anaphylaxis in the rat. Am J Physiol 1988; 255: G505-11.
68. Nanda R, James R, Smith H, Dudley CRK, Jewell DP. Food intolerance and the irritable bowel syndrome. Gut 1989; 30: 1098-104.
69. Oddsson E, Rask-Madsen J, Krag E. A secretory epithelium of the small intestine with increased sensitivity to bile acids in irritable bowel syndrome associated with diarrhoea. Scand J Gastroenterol 1978; 13: 409-16.
70. Merrick MV, Eastwood MA, Ford MJ. Is bile acid malabsorption underdiagnosed ? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br Med J 1985; 290: 665-8.
71. Spiller RC, Brown ML, Phillips SF. Decreased fluid tolerance, accelerated transit, and abnormal motility of the human colon induced by oleic acid. Gastroenterology 1986; 91: 100-7.
72. Kamath PS, Hoepfner MT, Phillips SF. Short-chain fatty acids stimulate motility of the canine ileum. Am J Physiol 1987; 253: G427-33.
73. Camilleri M, Prather CM. The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med 1992; 116: 1001-8.
74. Bond JH, Levitt MD. Quantitative measurement of lactose absorption. Gastroenterology 1976; 70: 1058-62.
75. Cann PA, Read NW, Holdsworth CD, Barends D. Role of loperamide and placebo in the management of irritable bowel syndrome (IBS). Dig Dis Sci 1984; 29: 239-47.
76. Greenbaum DS, Mayle JE, Vanegeren LE, et al. Effects of desipramine on irritable bowel syndrome compared with atropine and placebo. Dig Dis Sci 1987; 32: 257-66.
77. Krevsky B, Maurer AH, Niewiarowski T, Cohen S. Effect of verapamil on human intestinal transit. Dig Dis Sci 1992; 37: 919-24.
78. Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988; 95: 232-41.
79. Kruis W, Weinzierl M, Schussler P, Holl J. Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome. Digestion 1986; 34: 196-201.
80. Tasman-Jones C. Mebeverine in patients with the irritable colon syndrome: double blind study. N Z Med J 1973; 77: 232-5.
81. Capurso L, Koch M, Tarquini M, et al. The irritable syndrome: A cross-over study of octilonium bromide, mebeverine and placebo. Clin Trials J 1984; 21: 285-91.
82. Bertheiot J, Centonze M. Etude contrôllée en double aveugle Duspatalin (Mébévérine) contre placebo, dans le traitement du côlon irritable. Gaz Med Fr 1981; 88: 2343.
83. Dew MJ, Evans BK, Rhodes J. Peppermint oil for the irritable bowel syndrome: a multicentre trial. Br J Clin Pract 1995; 38: 394.
84. Nash P, Gould SR, Bernardo DE. Peppermint oil does not relieve the pain of irritable bowel syndrome. Br J Clin Pract 1986; 40: 292-3.
85. Rees WD, Evans BK, Rhodes J. Treating irritable bowel syndrome with peppermint oil. Br Med J 1979; 2: 835-6.
86. Piai G, Mazzacca G. Prifinium bromide in the treatment of the irritable colon syndrome. Gastroenterology 1979; 77: 500-2.
87. Moshal MG, Herron M. A clinical trial of trimebutine (Mebutin) in spastic colon. J Int Med Res 1979; 7: 231-4.
88. Fielding JF. Double-blind trial of trimebutine in the irritable bowel syndrome. Ir Med J 1980; 73: 377-9.
89. Dobrilla G, Imbimbo BP, Piazzi L, Bensi G. Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double-blind, placebo-controlled clinical trial. Gut 1990; 31: 355-8.
90. Piai G, Visconti M, Imbimbo B, et al. Long-term treatment of irritable bowel syndrome with cimetropium bromide, a new antimuscarinic compound. Curr Ther Res 1987; 41: 967-77.
91. Centonze V, Imbimbo BP, Campanozzi F. et al. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome. Am J Gastroenterol 1988; 83: 1262-6.
92. Page JG, Dirnberger GM. Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride). J Clin Gastroenterol 1981; 3: 153-6.
93. Schafer E, Ewe K. Efficacy and toleration of Buscopan plus buscopan, paracetamol and placebo in ambulatory patients with IBS. Fortschr Med 1990; 108: 488-92.
94. Matts SG. An assessment of dicyclomine hydrochloride (Merbentyl) in the irritable colon syndrome. Br J Clin Pract 1967; 21: 549-51.
95. Connell AM. Physiological and clinical assessment of the effect of the musculotropic agent mebeverine on the human colon. Br Med J 1965; 2: 848-51.
96. Misra SP, Thorat VK, Sachdev GK, Anand BS. Long-term treatment of irritable bowel syndrome: results of a randomized controlled trial. Q J Med 1989; 73:931-9.
97. Baldi F, Longanesi A, Blasi A, et al. Octylonium bromide in the treatment of the irritable bowel syndrome : a clinical-functional study. Hepatogastroenterology 1992; 39: 392-5.
98. Levy C, Charbonnier A, Cachin M. Pinaverium bromide and functional colonic disease (double-blind study). Sem Hopitaux Ther 1977; 53: 372-4.
99. Poynard T, Naveau S, Mory B, Chaput JC. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 499-510.
100. Dapoigny M, Abitbol JL, Fraitag B. Efficacy of peripheral kappa agonist, fedotozine, vs. placebo in treatment of irritable bowel syndrome. A multicenter dose-response study. Dig Dis Sci 1995; 40; 2244-9.
101. 2 excretion after ingestion of complex carbohydrates. Gastroenterology 1987; 92: 383-9.
102. Ravich WJ, Bayless TM, Thomas M. Fructose; incomplete intestinal absorption in humans. Gastroenterology 1983; 84: 26-9.
103. Whorwell PJ, Prior A, Faragher EB. Hypnotherapy in irritable bowel syndrome. Lancet 1984; ii: 1232-4.
104. Svedlund J. Psychotherapy in irritable bowel syndrome: a controlled outcome study. Acta Psychiatr Scand 1983; 67 (Suppl. 306): 1-86.
105. Guthrie E, Creed F, Dawson D, Tomerson B. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991; 100: 450-7.
106. Whorwell PJ. Hypnotherapy in the irritable bowel syndrome. Stress Med 1987; 3: 5-7.
107. Cann PA, Read NW. Holdsworth CD. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 1984; 25: 168-73.
108. Prior A, Whorwell PJ. Clinical trial: double-blind study of ipaghula in irritable bowel syndrome. Gut 1987; 28: 1510-3.
109. Camilleri M, Thompson WG, Fleshman JW, Pemberton JH. Clinical management of intractable constipation. Ann Intern Med 1994; 121: 520-8.